Abstract
Malignant cells harbor mechanisms which allow escape from drug-induced apoptosis, and the drug-resistance phenotype can be significantly associated with resistance to programmed cell death. There is accumulating evidence that mitochondria play a role in the tumorigenic phenotype, including the relative resistance to apoptosis. Whether changes at the mitochondrial level per se, would impact on the relative sensitivity of malignant cells to undergo drug-induced apoptosis, is not know. Accordingly, we determined if depleting mitochondrial DNA (mtDNA) would change the susceptibility of U937 cells to undergo apoptosis. With depletion, increases in sensitivity to cis-diamminedichoroplatinum (cisplatin)-induced apoptosis was observed. This sensitivity could be reverted to the parental phenotype by transforming the depleted cells with normal platelet mitochondria. mRNA expression of BAX, BCL2, MDR1, MRP, ERCC1 and ERCC2, putatively associated with cisplatin resistance to apoptotic death was unchanged. Inhibition of mitochondrial ATP production by oligomycin did not result in a change in ATP levels, indicating energetics were not playing a role in the observed phenotype changes. All U937 cells (with/without mtDNA) continued to respond to cisplatin by an apoptotic death. MtDNA-encoded molecules may be playing a role in the relative sensitivity of cells to undergo a cisplatin-induced apoptotic death, but may not be required for cells to undergo apoptosis per se.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Edited by J.C. Reed
Rights and permissions
About this article
Cite this article
Liang, B., Ullyatt, E. Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletion. Cell Death Differ 5, 694–701 (1998). https://doi.org/10.1038/sj.cdd.4400401
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400401
Keywords
This article is cited by
-
Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line
BMC Cancer (2014)
-
Contribution of intracellular ATP to cisplatin resistance of tumor cells
JBIC Journal of Biological Inorganic Chemistry (2013)
-
The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies
Journal of Bioenergetics and Biomembranes (2007)
-
Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer
Journal of Bioenergetics and Biomembranes (2007)
-
Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma
British Journal of Cancer (2006)